AGL 8.00 Decreased By ▼ -0.15 (-1.84%)
ANL 11.32 Increased By ▲ 0.23 (2.07%)
AVN 83.45 Decreased By ▼ -0.25 (-0.3%)
BOP 5.85 No Change ▼ 0.00 (0%)
CNERGY 5.85 Increased By ▲ 0.20 (3.54%)
EFERT 80.10 Decreased By ▼ -0.12 (-0.15%)
EPCL 67.29 Increased By ▲ 0.01 (0.01%)
FCCL 15.20 No Change ▼ 0.00 (0%)
FFL 7.04 Decreased By ▼ -0.19 (-2.63%)
FLYNG 7.77 Decreased By ▼ -0.29 (-3.6%)
GGGL 11.90 Decreased By ▼ -0.10 (-0.83%)
GGL 17.65 Decreased By ▼ -0.06 (-0.34%)
GTECH 9.18 Increased By ▲ 0.40 (4.56%)
HUMNL 7.20 Decreased By ▼ -0.03 (-0.41%)
KEL 3.50 Decreased By ▼ -0.24 (-6.42%)
LOTCHEM 30.95 Decreased By ▼ -1.15 (-3.58%)
MLCF 28.52 Decreased By ▼ -0.48 (-1.66%)
OGDC 85.20 Decreased By ▼ -0.85 (-0.99%)
PAEL 17.11 Decreased By ▼ -0.29 (-1.67%)
PIBTL 6.15 Decreased By ▼ -0.15 (-2.38%)
PRL 19.84 Increased By ▲ 0.74 (3.87%)
SILK 1.29 Increased By ▲ 0.10 (8.4%)
TELE 12.05 Decreased By ▼ -0.20 (-1.63%)
TPL 9.16 Decreased By ▼ -0.02 (-0.22%)
TPLP 20.19 Decreased By ▼ -0.51 (-2.46%)
TREET 27.10 Increased By ▲ 0.15 (0.56%)
TRG 97.30 Decreased By ▼ -0.45 (-0.46%)
UNITY 22.83 Decreased By ▼ -0.17 (-0.74%)
WAVES 13.29 Decreased By ▼ -0.81 (-5.74%)
WTL 1.45 Increased By ▲ 0.14 (10.69%)
BR100 4,361 Decreased By -27.2 (-0.62%)
BR30 16,009 Decreased By -90.5 (-0.56%)
KSE100 43,482 Decreased By -195.1 (-0.45%)
KSE30 16,476 Decreased By -56.6 (-0.34%)

US Food and Drug Administration

Our dietary intake
Opinion

Our dietary intake

I was reading the latest article on a website called IFL Science about monosodium glutamate (MSG) and as a medical...
Published 22 Apr, 2022 05:36am
Moderna files for full US approval of COVID-19 vaccine
World

Moderna files for full US approval of COVID-19 vaccine

  • The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States.
  • Moderna said it will continue to submit data to the US Food and Drug Administration on a rolling basis over the coming weeks with a request for a priority review.
Published 01 Jun, 2021 07:14pm
Moderna says its COVID-19 vaccine found safe, effective in teens
Business & Finance

Moderna says its COVID-19 vaccine found safe, effective in teens

  • Moderna Inc, whose vaccine is authorized for adults 18 and older, said it will submit the findings of its adolescent study to the US Food and Drug Administration and other regulators for emergency use authorization in early June.
  • US regulators took about a month to review a similar study from Pfizer/BioNtech, which was authorized for ages 12-15 on May 10. If Moderna gets the same treatment, its authorization would come in early July.
Published 25 May, 2021 05:33pm
Pfizer COVID-19 shot 91pc effective in updated data, protective against South African variant
World

Pfizer COVID-19 shot 91pc effective in updated data, protective against South African variant

  • The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800.
  • While the new overall efficacy rate of 91.3% is lower than the 95% originally reported in November for its 44,000-person trial, a number of variants have become more prevalent around the world since then.
Published 01 Apr, 2021 06:23pm
US FDA approves J&J's multiple sclerosis treatment
World

US FDA approves J&J's multiple sclerosis treatment

  • The FDA approved Ponvory as a daily oral drug to treat relapsing forms of multiple sclerosis, a debilitating neurological condition in which the immune system eats away at the protective covering of nerves.
Published 19 Mar, 2021 07:06pm
Citigroup offers rapid at-home COVID-19 tests to some US staff
World

Citigroup offers rapid at-home COVID-19 tests to some US staff

  • The at-home COVID-19 testing program uses a rapid antigen test, which offers results within 20 minutes, the bank said, adding the test is awaiting emergency use approval from the US Food and Drug Administration.
  • Citi said it has offered employees at its Chicago area branches and those working on its trading floors in New York a chance to participate in the home testing program.
Published 10 Mar, 2021 07:38pm
Abbott's test to distinguish coronavirus and flu viruses gets US authorization
World

Abbott's test to distinguish coronavirus and flu viruses gets US authorization

  • The test, Alinity m Resp-4-Plex, can be conducted with one nasal swab sample and can differentiate the coronavirus, flu A, flu B and another respiratory virus called respiratory syncytial virus (RSV), the company said.
  • Abbott has a range of COVID-19 tests, including antigen, molecular and serology tests which have been authorized for emergency use by the US Food and Drug Administration.
Published 05 Mar, 2021 09:09pm